» Articles » PMID: 37460987

A Novel Mutation in the TTN Gene Resulted in Left Ventricular Noncompaction: a Case Report and Literature Review

Overview
Publisher Biomed Central
Date 2023 Jul 17
PMID 37460987
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Left ventricular noncompaction (LVNC) is a specific type of cardiomyopathy characterized by coarse trabeculae and interspersed trabecular crypts within the ventricles. Clinical presentation varies widely and may be nonsignificant or may present with progressive heart failure, malignant arrhythmias, and multiorgan embolism. The mode of inheritance is highly heterogeneous but is most commonly autosomal dominant. The TTN gene encodes titin, which is not only an elastic component of muscle contraction but also mediates multiple signalling pathways in striated muscle cells. In recent years, mutations in the TTN gene have been found to be associated with LVNC, but the exact pathogenesis is still not fully clarified.

Case Presentation: In this article, we report a case of an adult LVNC patient with a TTN gene variant, c.87857G > A (p. Trp29286*), that has not been reported previously. This 43-year-old adult male was hospitalized repeatedly for heart failure. Echocardiography showed reduced myocardial contractility, dilated left ventricle with many prominent trabeculae, and a loose texture of the left ventricular layer of myocardium with crypt-like changes. During the out-of-hospital follow-up, the patient had no significant signs or symptoms of discomfort.

Conclusion: This case report enriches the mutational spectrum of the TTN gene in LVNC and provides a basis for genetic counselling and treatment of this patient. Clinicians should improve their understanding of LVNC, focusing on exploring its pathogenesis and genetic characteristics to provide new directions for future diagnosis and treatment.

References
1.
Deo R . Alternative Splicing, Internal Promoter, Nonsense-Mediated Decay, or All Three: Explaining the Distribution of Truncation Variants in Titin. Circ Cardiovasc Genet. 2016; 9(5):419-425. PMC: 5068190. DOI: 10.1161/CIRCGENETICS.116.001513. View

2.
Roberts A, Ware J, Herman D, Schafer S, Baksi J, Bick A . Integrated allelic, transcriptional, and phenomic dissection of the cardiac effects of titin truncations in health and disease. Sci Transl Med. 2015; 7(270):270ra6. PMC: 4560092. DOI: 10.1126/scitranslmed.3010134. View

3.
Hoedemaekers Y, Caliskan K, Michels M, Frohn-Mulder I, van der Smagt J, Phefferkorn J . The importance of genetic counseling, DNA diagnostics, and cardiologic family screening in left ventricular noncompaction cardiomyopathy. Circ Cardiovasc Genet. 2010; 3(3):232-9. DOI: 10.1161/CIRCGENETICS.109.903898. View

4.
Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J . Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015; 17(5):405-24. PMC: 4544753. DOI: 10.1038/gim.2015.30. View

5.
Towbin J, Lorts A, Jefferies J . Left ventricular non-compaction cardiomyopathy. Lancet. 2015; 386(9995):813-25. DOI: 10.1016/S0140-6736(14)61282-4. View